Pharmaceutical Executive Digest:
Having trouble viewing this e-mail? Click here.
Pharmaceutical Executive Europe  E-News
 
 
 
 
 
 

You can now follow us on Twitter at Twitter.com/pharmexecdigi
 
Survey
We asked 40 pharma leaders, who should be driving universal anticounterfeiting solutions?

Pharma 48%
Regulators 43%
Vendors 9%

Talk to us:
jupton@advanstar.com

Advertise with us: mgoodrich@advanstar.com

15 May, 2012
In this Issue
Taxing Times for French Pharma
In the shadow of the French Presidential campaign, the pharmaceutical industry seized the chance to lobby for equitable taxation to give the sector a much-needed boost. Read more...
Polish Bid for Biotech Glory
How Poland's government is aiming to make the country a biotech powerhouse. Sean Milmo reports. More...
Using Social Networks to Improve Sales
Social networks existed long before Mark Zuckerberg came along. What hasn't existed until recently are the tools, metrics and case studies necessary to understand how physicians influence each other within professional networks . More...
Going the Distance in Digital Advertising
For pharma, simply moving traditional marketing materials and tactics from print to online is not enough — a true digital transition must be interactive to be effective writes Jennifer Ringler. More...
Product Profile
NNIT
GxP Cloud now with SaaS
With validated GxP applications ready as SaaS in NNIT's GxP Cloud you can save deployment and validation costs as well as time. Read more
Sciformix
Establishing Case Quality Metrics - defining and using quality metrics for adverse events case processing. Read more

Case Study
Reducing outsourcing costs and cycle-times
Discover how a biotech saved $600,000 on a Phase II contract, compressed the contracting cycle-time from three months to two weeks, and formed a more constructive and collaborative working relationship with their CRO. Download the case study today.


Event Profile
Global Publication Planning & Clinical Trial Registries Forum
Strategies for Effective and Compliant Data Dissemination and Coordination
11-12 June 2012
Amsterdam, Netherlands
The relationship between journal publications and trial databases is essential for full disclosure of clinical results information to the public. At the Global Publication Planning and Clinical Trial Registries Forum. Read more
Also in this issue…
Sanofi Ireland Site Receives Approval
Service Providers Should 'Channel Steve Jobs'
EFPIA Advances Medicines Verification Project